2015
DOI: 10.1016/j.circir.2014.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Detección primaria del cáncer cervicouterino

Abstract: Cervico-uterine cancer screening with cytology decrease incidence by more than 50%. The cause of this cancer is the human papilloma virus high risk, and requires a sensitive test to provide sufficient sensitivity and specificity for early detection and greater interval period when the results are negative. The test of the human papilloma virus high risk, is effective and safe because of its excellent sensitivity, negative predictive value and optimal reproducibility, especially when combined with liquid-based … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
5

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 34 publications
0
5
0
5
Order By: Relevance
“…To reduce the high rates of mortality from cervical cancer is necessary to institute measures of innovation and equity; create sex education campaigns, increase screening coverage and provided women with geographical, cultural or economic barriers; free universal application of the HPV vaccine and the full treatment for all women's [26].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To reduce the high rates of mortality from cervical cancer is necessary to institute measures of innovation and equity; create sex education campaigns, increase screening coverage and provided women with geographical, cultural or economic barriers; free universal application of the HPV vaccine and the full treatment for all women's [26].…”
Section: Discussionmentioning
confidence: 99%
“…months, mainly applied in high schools and 80% coverage in adolescents 12 to 13 years, a reduction of 63% of cervical cancer, 51% reduction of CIN-3 is projected and 27% reduction of abnormal smears before 30 years of age [25][26][27][28]. …”
Section: Hpv Vaccinementioning
confidence: 99%
“…El manejo de la NIC-1 y 2 es controvertido pues algunas remiten espontáneamente y otras no. Los procedimientos destructivos se emplean de inicio a las pacientes que están en mayor riesgo de progresión; a las de bajo riesgo se observan si remiten espontáneamente, aun cuando es difícil predecir el resultado individual de cada paciente (26,27). e258 Revista Médica Sinergia Vol.…”
Section: Conductaunclassified
“…HPVs are classified as high or low risk. Infections with low-risk genotypes are generally self-limited and do not lead to malignancy, HPV-ar infections (HPV- 16,18,31,33,35,39,45,51,52,55,56,58, genotypes 59, 68, 73, 82 and 83) are associated with the development of cancers where 96% are positive for HPV-ar, mainly for cervical cancer [6,[29][30].…”
Section: Introductionmentioning
confidence: 99%